First report of macrolide resistance in a mycoplasma pneumoniae isolate causing community-acquired pneumonia in Spain

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 2, 2014, Pages 1265-1266

  De Dios Caballero, Juan ^a,b,c   Del Campo, Rosa ^a,b,c   Del Carmen Mafé, María ^a   Gálvez, María ^a   Rodríguez Domínguez, Mario ^a,b,c   Cantón, Rafael ^a,b,c   Meseguer, María Antonia ^a   Hermida, José Manuel ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b INSTITUTO RAMÓN Y CAJAL DE INVESTIGACIÓN SANITARIA IRYCIS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMUNITY ACQUIRED PNEUMONIA; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA HOMINIS; MYCOPLASMA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; SPAIN; UREAPLASMA;

ANTI-BACTERIAL AGENTS; CHINA; COMMUNITY-ACQUIRED INFECTIONS; DOXYCYCLINE; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; POLYMERASE CHAIN REACTION; SPAIN; TRAVEL; YOUNG ADULT;

EID: 84893495299     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02325-13     Document Type: Letter

References (12)

1. Waites KB, Talkington DF. 2004. Mycoplasma pneumoniae and its role as a human pathogen. Clin. Microbiol. Rev. 17:697-728. http://dx.doi.org/10.1128/CMR. 17.4.697-728.2004.
2. Morozumi M, Takahashi T, Ubukata K. 2010. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J. Infect. Chemother. 16:78-86. http://dx.doi.org/10.1007/s10156-009-0021-4.
3. Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, Chiba N, Iwata S, Ubukata K. 2012. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin. Infect. Dis. 55: 1642-1649. http://dx.doi.org/10. 1093/cid/cis784.
4. Zhao F, Liu G, Wu J, Cao B, Tao X, He L, Meng F, Zhu L, Lv M, Yin Y, Zhang J. 2013. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob. Agents Chemother. 57:1521-1523. http://dx.doi.org/10.1128/AAC.02060-12.
5. Yoo SJ, Kim HB, Choi SH, Lee SO, Kim SH, Hong SB, Sung H, Kim MN. 2012. Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with communityacquired pneumonia: clinical impact of mutations conferring macrolide resistance. Antimicrob. Agents Chemother. 56:6393-6396. http://dx.doi.org/10.1128/AAC.01421-12.
6. Dumke R, von Baum H, Lück PC, Jacobs E. 2010. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin. Microbiol. Infect. 16:613-616. http://dx.doi.org/10.1111/j.1469-0691.2009.02968.x.
7. Peuchant O, Ménard A, Renaudin H, Morozumi M, Ubukata K, Bébéar CM, Pereyre S. 2009. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J. Antimicrob. Chemother. 64:52-58. http://dx.doi.org/10.1093/jac/dkp160.
8. Uldum SA, Bangsborg JM, Gahrn-Hansen B, Ljung R, Mlvadgaard M, Fns Petersen R, Wiid Svarrer C. 2012. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill. 17:pii20073.
9. Spuesens EB, Meijer A, Bierschenk D, Hoogenboezem T, Donker GA, Hartwig NG, Koopmans MP, Vink C, van Rossum AM. 2012. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands. J. Clin. Microbiol. 50:1999-2004. http://dx.doi.org/10.1128/JCM.00400-12.
10. Waites KB, Bébéar CM, Robertson JA, Talkington DF, Kenny GE. 2001. Cumitech 34, Laboratory diagnosis of mycoplasmal infections. Coordinating ed, Nolte FS. ASM Press, Washington, DC.
11. Clinical and Laboratory Standards Institute (CLSI). 2011. Methods for antimicrobial susceptibility testing for human mycoplasmas; approved guideline. Document M43-A. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. 2008. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob. Agents Chemother. 52:3542-3549. http://dx.doi.org/10.1128/AAC.00582-08.